Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jun 8;18(1):268.
doi: 10.1186/s13063-017-2002-8.

The efficacy and safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean patients with cold hypersensitivity in the hands: study protocol for a pilot, double-blind, randomized, placebo-controlled, parallel-group clinical trial

Affiliations
Randomized Controlled Trial

The efficacy and safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean patients with cold hypersensitivity in the hands: study protocol for a pilot, double-blind, randomized, placebo-controlled, parallel-group clinical trial

Youme Ko et al. Trials. .

Abstract

Background: In recent years, cold hypersensitivity in the hands (CHH) has become a common ailment of women in Korea. It can lead to gynecological problems such as irregular menstruation, miscarriage, and infertility. Traditionally, Korean herbal medicine has been the primary treatment method used to balance thermoregulation in the human body; however, its effectiveness has not been confirmed through systematic study. Thus, in this trial, we will investigate the feasibility of a full randomized clinical trial, Danggui-Sayuk-Ga-Osuyu-Saenggang-tang (DSGOST) in Korean women with CHH.

Methods: This study will be a pilot, multicenter, double-blind, randomized, parallel-group, two-arm, placebo-controlled clinical trial. A total of 66 participants will be randomly divided into two groups, a DSGOST treatment group and a placebo control group, in a 1:1 ratio using a web-based randomization system. Each group will take DSGOST or placebo three times daily for 6 weeks. The primary outcome will be measured using Visual Analogue Scale (VAS) scores of CHH. Secondary outcomes will include changes in skin temperature of the hands, Clinical Global Impressions (CGI) scale scores, recovery rate of skin temperature of the hands after the cold stress test, and the Korean version of the WHO Quality of Life Scale, abbreviated version (WHOQOL-BREF).

Discussion: This trial will be the first trial to reflect the newly defined disease range of CHH which was compiled by Korean medicine expert consensus. This study will provide considerable evidence for further large-scale trials and general clinical guidelines for CHH in the Korean medical field.

Trial registration: This study is registered at ClinicalTrials.gov, ID: NCT02645916 . Registered on 30 December 2015.

Keywords: Cold hypersensitivity; Cold temperature; Herbal medicine; Randomized clinical trial.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of the trial process
Fig. 2
Fig. 2
Study schedule of the Danggui-Sayuk-Ga-Osuyu-Saenggang-tang (DSGOST) clinical trial

Similar articles

Cited by

References

    1. Sun SH, Go HY, Ko SW, Cho YY, Shin JH, Kim TH, et al. A Delphi study for treatment standardization of coldness in hands and Feet. J Soc Preven Korean Med. 2015;19(3):131–140.
    1. Bae KH, Lee JA, Park KH, Yoo JH, Lee Y, Lee S. Cold hypersensitivity in the hands and feet may be associated with functional dyspepsia: results of a multicenter survey study. Evid Based Complement Alternat Med. 2016;2016:8948690. - PMC - PubMed
    1. Hur YM, Chae JH, Chung KW, Kim JJ, Jeong HU, Kim JW, et al. Feeling of cold hands and feet is a highly heritable phenotype. Twin Res Hum Genet. 2012;15(2):166–169. doi: 10.1375/twin.15.2.166. - DOI - PubMed
    1. Lee SL, Lee KS, Song BK. The literature review on the cold hypersensitivity of women. Korean J Obstet Gynecol. 1996;9:55–80.
    1. Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatology (Oxford) 2005;44(5):587–596. doi: 10.1093/rheumatology/keh552. - DOI - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

Associated data

LinkOut - more resources